MARY TAYLOR: Open Payments
NPI 1699907451 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 58 payments from 11 companies in 2025. Trend: 2023 $148 · 2024 $325 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $303 |
| ABBVIE INC. | 19 | $190 |
| Medtronic, Inc. | 3 | $182 |
| Astellas Pharma US Inc | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Exact Sciences Corporation | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, MINIMED 780G, Veozah, Kerendia, Cologuard Collection Kit, BREZTRI, HETLIOZ.
Industry payments across KY — which companies pay providers there.
